Abundes-Corona RA, Corona VT

Language: Spanish
References: 23
Page: 362-366
PDF size: 193.23 Kb.

ABSTRACT

The life of Vincent van Gogh (1853-1890) has been studied thoroughly by humanists and scientists alike. His biography is an archetype of the relationship between creativity and disease. In 1956, Henri Gastaut defined his diagnosis as temporal lobe epilepsy. The artist was known for an eccentric personality and unpredictable mood, with recurrent psychotic bouts through the last two years of his life. Several authors have considered the possibility that van Gogh also suffered from bipolar affective disorder. We conducted a biographical and epistolary review with the objective of analyzing the complexity of his disease and the effects it had on his art, which ultimately placed him as one of the greatest geniuses in art.

REFERENCES

1. Kurosawa A (dir.) Dreams. Warner Bros., 1990. Filme.

2. Artaud A. Le suicidé de la société. París: K Editeur; 1947.

3. Corona T. Art and Medicine. Arch Inst Nac Neurol Neurocir. 1994;9:41-3.

4. Blumer D. The illnes of Vincent van Gogh. Am J Psychiatry. 2002;159(4):519-26.

5. Martin C. Did Van Gogh have Ménière’s disease? Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(4):205-9.

6. Arenberg IK, Countryman LF, Bernstein LH, Shambaugh GE Jr. Van Gogh had Ménière’s disease and not epilepsy. JAMA. 1990;264(4):491-3.

7. Corona T, Jiménez-Gil FJ, Estañol B. Los girasoles de Van Gogh, enfermedad mental y epilepsia. Rev Med IMSS. 1988;26:355.

8. González-Luque FJ, Montejo González L. Vincent Van Gogh and the toxic colors of Saturn. Salamanca: Universidad de Salamanca; 2004.

9. Gastaut H. [Vincent van Gogh’s disease seen in the light of new concepts of psychomotor epilepsy]. Ann Med Psychol (Paris). 1956;114(2):196-238.

10. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol. 2003;16(2):165-70.

11. Téllez-Zenteno JF, Hernández-Ronquillo L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat. 2012;2012:630853.

12. Mula M. The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal. Postgrad Med. 2010;122(4):14-23.

13. Jobe PC. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches. Clin EEG Neurosci. 2004; 35(1):53-68.

14. Fiest K, Dykeman J, Patten S, et al. Depression in epilepsy: A systematic review adn meta-analysis. Neurology. 2013;80:1-10.

15. Doucet GE, Skidmore C, Sharan AD, Sperling MR, Tracy JI. Functional connectivity abnormalities vary by amygdala subdivision and are associated with psychiatric symptoms in unilateral temporal epilepsy. Brain Cogn. 2013;83(2):171-82.

16. Pitkänen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet. 2011; 10(2):173-86.

17. Pitkänen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 2009;14 Suppl 1:16.

18. McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol. 2001;63:815-46.

19. Chang BS, Lowenstein DH. Epilepsy. N Engl J Med. 2003;349(13):1257-66.

20. Rogawski MA. KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 2000;23(9):393-8.

21. Segall P. The rewards of chronic illness. West J Med. 2001;175(5):347-8.

22. Bogousslavsky J, Boller F. Neurological disorders in famous artists. Basilea: Karger; 2005.

23. The complete letters of Vincent van Gogh. Minnetonka, MN: Bullfinch Press; 2002.